Prosper provides at-home genetic, epigenetic and microbiome tests for people and their pets.
Market:
Genetic testing services for humans and their companion animals is a $4B market growing at approximately 11% per year. Epigenetic and microbiome testing are new market opportunities.Technology:
Prosper combines targeted high-throughput sequencing and their proprietary databases of genetic, epigenetic, and microbiome phenotype correlations to provide individualized health and wellness insights to their customers.Advantages:
- Unique health and wellness insights
- Low cost
- Rapid results
Development Stage:
- Canine tests for genetic, epigenetic, and microbiome markers are commercially available.
- Feline products are in pre-launch testing.
- Human tests are in development.
Select Publications:
- Coming soon
Contact:
Website: prosperk9.comPhone: 805-807-1721
Back to Top
August 30, 2024 | CNSI Magnify company, Prosper DNA, helps pet lovers provide better care through breed, age, personality, and health testing
CNSI Magnify company, Prosper DNA, helps pet lovers provide better care through breed, age, personality, and health testing By Nicole Wilkins Prosper DNA can help owners determine appropriate strategies to enhance their dog’s wellness....
Portfolio Companies
- Anaco
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- Diatom Biolab
- Eximius Diagnostics
- Giant BioSystems
- Hikari Medical Technologies
- ImmunoVec
- MedStat AI Inc.
- Mervyn's Petcare, Inc.
- Meteor Biotech, LLC
- My Block Skin, Inc.
- Nanomega CryoAI
- NEXT-TFX, Inc.
- Paralos Bioscience Inc.
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Prosper DNA
- Protean Research, Inc.
- Purpose Bio
- RaizDx
- RiboForge
- Saku Biosciences, Inc.
- SolGrapH, Inc.
- Sorriso Pharmaceuticals
- Thermeutics, Inc.
- Vault Pharma
- Veergen, Inc.
- Yuyu Bio, Inc.